Detalhe da pesquisa
1.
Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.
Cancer Treat Res Commun
; 15: 21-31, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207284